531739 — Gennex Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Gennex Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	272	223	1,163	1,263	54.2
Net Total Accounts Receivable
Net Total Receivables	113	94.2	178	142	1,518
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	472	487	1,618	1,811	2,647
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	137	676	550	618	711
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	680	1,323	2,300	2,560	3,487
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	242	295	403	446	724
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	242	520	596	693	1,262
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	438	803	1,704	1,867	2,225
Total Liabilities & Shareholders' Equity	680	1,323	2,300	2,560	3,487
Total Common Shares Outstanding